Delivery Order SPE2D018D0006-SPE2D325F1298
Award Date
11/6/24
Potential Completion Date
11/12/24
Potential Value
$5.1K
Federal Agency
Medical Supply Chain
Awardee
Eagle Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, NJ 07677, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a total ceiling value of $5,292.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is a delivery order (SPE2D325F5036) for the supply of Ryanodex, a 250mg injectable medication used for treating and preventing malignant hyperthermia in high-risk patients. The contract is a firm fixed-price arrangement with a period of performance ending on January 31,...
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Ryanodex (250mg vials). The contract has a firm fixed price of $92,838.80 and a period of performance through April 6, 2023. This award is part of Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
This is a firm fixed-price delivery order contract (SPE2D018D0006|SPE2D325F4806) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of Ryanodex (250 mg vials), a drug used to treat and prevent malignant hyperthermia. The contract has a ceiling value of $10,585.32 and an ultimate completion date of January 29, 2025. This award is not associated with a set-aside program. Eagle...
Eagle Pharmaceuticals, Inc. has been awarded a $4,874.13 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 250mg vials of the drug Ryanodex. As the prime contractor, Eagle Pharmaceuticals will deliver the specified pharmaceutical products to DLA Troop Support Medical's place of performance in Westwood, New Jersey by November 15, 2023. No major subcontractors or joint venture partners are involved. The delivery order was...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,632.64, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,623.36 firm fixed price delivery order is for the supply of RYANODEX 250 MG VIALS, a critical medical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
This federal contract award, valued at $4,287.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a completion date of February 23, 2023. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is for the delivery of RYANODEX 250MG VIAL 1S, a medical supply product, with a ceiling value of $4,816.32 and a performance period ending on July 17, 2025. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYANODEX 250 MG VIALS. The contract has a total ceiling value of $5,958.56 and is a fixed-price delivery order with a performance period through September 16, 2024. The contract is not set aside for any specific business type. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...